Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Emmenegger M, et al. Among authors: rose l. PLoS Pathog. 2022 Feb 2;18(2):e1010289. doi: 10.1371/journal.ppat.1010289. eCollection 2022 Feb. PLoS Pathog. 2022. PMID: 35108341 Free PMC article.
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Emmenegger M, et al. Among authors: rose l. PLoS Pathog. 2021 Dec 3;17(12):e1010118. doi: 10.1371/journal.ppat.1010118. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34860860 Free PMC article.
Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V, Rose L, Hiemann R, Nasser A, Rödiger S, Bonaventura A, Winkler L, Sowa M, Stöckle M, Schierack P, Junker K, Roggenbuck D. Liedtke V, et al. Among authors: rose l. Int J Mol Sci. 2023 Mar 24;24(7):6166. doi: 10.3390/ijms24076166. Int J Mol Sci. 2023. PMID: 37047137 Free PMC article.
Cosmetic considerations after breast cancer treatment.
Rose L, Mallela T, Waters M, Novice M, Minta A, Akintilo L, Shipp D, Dulmage B. Rose L, et al. Arch Dermatol Res. 2024 May 24;316(6):223. doi: 10.1007/s00403-024-02898-1. Arch Dermatol Res. 2024. PMID: 38787423 Review.
Mixed-method evaluation study of a targeted mass drug administration of long-acting anti-malarials among children aged 3 months to 15 years in the Bossangoa sub-prefecture, Ouham, Central African Republic, during the COVID-19 pandemic.
Robinson E, Ouabo A, Rose L, van Braak F, Vyncke J, Wright R, Gray N, Sakama NS, Aboukar EJ, Fierte MM, Woinzoukou D, Ewers L, Serpande C, Stein S, Van Boetzelaer E, Kpahina OA, Sabe SC, Rao B, Kuehne A. Robinson E, et al. Among authors: rose l. Malar J. 2024 May 15;23(1):146. doi: 10.1186/s12936-024-04968-1. Malar J. 2024. PMID: 38750517 Free PMC article.
Eyebrow and Eyelash Loss in Patients With Cancer.
Rose L, Khuhro A, Minta A, Novice M, Novice T, Lustberg MB, Ruddy KJ, Rake EC, Loprinzi CL, Dulmage B. Rose L, et al. J Drugs Dermatol. 2024 May 1;23(5):327-331. doi: 10.36849/JDD.8003. J Drugs Dermatol. 2024. PMID: 38709698 Review.
1,426 results